Global and United States Gene Engineered Subunit Vaccine Market Size, Status and Forecast 2023-2027

Report ID: 1014639 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Therapeutic Gene Engineered Subunit Vaccine
        1.2.3 Preventative Gene Engineered Subunit Vaccine
    1.3 Market by Application
        1.3.1 Global Gene Engineered Subunit Vaccine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Human Use
        1.3.3 Veterinary Use
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Gene Engineered Subunit Vaccine Market Perspective (2016-2027)
    2.2 Gene Engineered Subunit Vaccine Growth Trends by Regions
        2.2.1 Gene Engineered Subunit Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Gene Engineered Subunit Vaccine Historic Market Share by Regions (2016-2021)
        2.2.3 Gene Engineered Subunit Vaccine Forecasted Market Size by Regions (2022-2027)
    2.3 Gene Engineered Subunit Vaccine Industry Dynamic
        2.3.1 Gene Engineered Subunit Vaccine Market Trends
        2.3.2 Gene Engineered Subunit Vaccine Market Drivers
        2.3.3 Gene Engineered Subunit Vaccine Market Challenges
        2.3.4 Gene Engineered Subunit Vaccine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Gene Engineered Subunit Vaccine Players by Revenue
        3.1.1 Global Top Gene Engineered Subunit Vaccine Players by Revenue (2016-2021)
        3.1.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Players (2016-2021)
    3.2 Global Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Gene Engineered Subunit Vaccine Revenue
    3.4 Global Gene Engineered Subunit Vaccine Market Concentration Ratio
        3.4.1 Global Gene Engineered Subunit Vaccine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Engineered Subunit Vaccine Revenue in 2020
    3.5 Gene Engineered Subunit Vaccine Key Players Head office and Area Served
    3.6 Key Players Gene Engineered Subunit Vaccine Product Solution and Service
    3.7 Date of Enter into Gene Engineered Subunit Vaccine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Engineered Subunit Vaccine Breakdown Data by Type
    4.1 Global Gene Engineered Subunit Vaccine Historic Market Size by Type (2016-2021)
    4.2 Global Gene Engineered Subunit Vaccine Forecasted Market Size by Type (2022-2027)

5 Gene Engineered Subunit Vaccine Breakdown Data by Application
    5.1 Global Gene Engineered Subunit Vaccine Historic Market Size by Application (2016-2021)
    5.2 Global Gene Engineered Subunit Vaccine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Gene Engineered Subunit Vaccine Market Size (2016-2027)
    6.2 North America Gene Engineered Subunit Vaccine Market Size by Type
        6.2.1 North America Gene Engineered Subunit Vaccine Market Size by Type (2016-2021)
        6.2.2 North America Gene Engineered Subunit Vaccine Market Size by Type (2022-2027)
        6.2.3 North America Gene Engineered Subunit Vaccine Market Size by Type (2016-2027)
    6.3 North America Gene Engineered Subunit Vaccine Market Size by Application
        6.3.1 North America Gene Engineered Subunit Vaccine Market Size by Application (2016-2021)
        6.3.2 North America Gene Engineered Subunit Vaccine Market Size by Application (2022-2027)
        6.3.3 North America Gene Engineered Subunit Vaccine Market Size by Application (2016-2027)
    6.4 North America Gene Engineered Subunit Vaccine Market Size by Country
        6.4.1 North America Gene Engineered Subunit Vaccine Market Size by Country (2016-2021)
        6.4.2 North America Gene Engineered Subunit Vaccine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Gene Engineered Subunit Vaccine Market Size (2016-2027)
    7.2 Europe Gene Engineered Subunit Vaccine Market Size by Type
        7.2.1 Europe Gene Engineered Subunit Vaccine Market Size by Type (2016-2021)
        7.2.2 Europe Gene Engineered Subunit Vaccine Market Size by Type (2022-2027)
        7.2.3 Europe Gene Engineered Subunit Vaccine Market Size by Type (2016-2027)
    7.3 Europe Gene Engineered Subunit Vaccine Market Size by Application
        7.3.1 Europe Gene Engineered Subunit Vaccine Market Size by Application (2016-2021)
        7.3.2 Europe Gene Engineered Subunit Vaccine Market Size by Application (2022-2027)
        7.3.3 Europe Gene Engineered Subunit Vaccine Market Size by Application (2016-2027)
    7.4 Europe Gene Engineered Subunit Vaccine Market Size by Country
        7.4.1 Europe Gene Engineered Subunit Vaccine Market Size by Country (2016-2021)
        7.4.2 Europe Gene Engineered Subunit Vaccine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size (2016-2027)
    8.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type
        8.2.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application
        8.3.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region
        8.4.1 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Gene Engineered Subunit Vaccine Market Size (2016-2027)
    9.2 Latin America Gene Engineered Subunit Vaccine Market Size by Type
        9.2.1 Latin America Gene Engineered Subunit Vaccine Market Size by Type (2016-2021)
        9.2.2 Latin America Gene Engineered Subunit Vaccine Market Size by Type (2022-2027)
        9.2.3 Latin America Gene Engineered Subunit Vaccine Market Size by Type (2016-2027)
    9.3 Latin America Gene Engineered Subunit Vaccine Market Size by Application
        9.3.1 Latin America Gene Engineered Subunit Vaccine Market Size by Application (2016-2021)
        9.3.2 Latin America Gene Engineered Subunit Vaccine Market Size by Application (2022-2027)
        9.3.3 Latin America Gene Engineered Subunit Vaccine Market Size by Application (2016-2027)
    9.4 Latin America Gene Engineered Subunit Vaccine Market Size by Country
        9.4.1 Latin America Gene Engineered Subunit Vaccine Market Size by Country (2016-2021)
        9.4.2 Latin America Gene Engineered Subunit Vaccine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size (2016-2027)
    10.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type
        10.2.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application
        10.3.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country
        10.4.1 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Gene Engineered Subunit Vaccine Introduction
        11.1.4 Merck Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.1.5 Merck Recent Development
    11.2 GSK
        11.2.1 GSK Company Details
        11.2.2 GSK Business Overview
        11.2.3 GSK Gene Engineered Subunit Vaccine Introduction
        11.2.4 GSK Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.2.5 GSK Recent Development
    11.3 Tiantan
        11.3.1 Tiantan Company Details
        11.3.2 Tiantan Business Overview
        11.3.3 Tiantan Gene Engineered Subunit Vaccine Introduction
        11.3.4 Tiantan Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.3.5 Tiantan Recent Development
    11.4 Pulike
        11.4.1 Pulike Company Details
        11.4.2 Pulike Business Overview
        11.4.3 Pulike Gene Engineered Subunit Vaccine Introduction
        11.4.4 Pulike Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.4.5 Pulike Recent Development
    11.5 Greffex
        11.5.1 Greffex Company Details
        11.5.2 Greffex Business Overview
        11.5.3 Greffex Gene Engineered Subunit Vaccine Introduction
        11.5.4 Greffex Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.5.5 Greffex Recent Development
    11.6 CureVac
        11.6.1 CureVac Company Details
        11.6.2 CureVac Business Overview
        11.6.3 CureVac Gene Engineered Subunit Vaccine Introduction
        11.6.4 CureVac Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.6.5 CureVac Recent Development
    11.7 Yebio
        11.7.1 Yebio Company Details
        11.7.2 Yebio Business Overview
        11.7.3 Yebio Gene Engineered Subunit Vaccine Introduction
        11.7.4 Yebio Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.7.5 Yebio Recent Development
    11.8 Sanofi Pasteur SA
        11.8.1 Sanofi Pasteur SA Company Details
        11.8.2 Sanofi Pasteur SA Business Overview
        11.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Introduction
        11.8.4 Sanofi Pasteur SA Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.8.5 Sanofi Pasteur SA Recent Development
    11.9 Virbac
        11.9.1 Virbac Company Details
        11.9.2 Virbac Business Overview
        11.9.3 Virbac Gene Engineered Subunit Vaccine Introduction
        11.9.4 Virbac Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.9.5 Virbac Recent Development
    11.10 Pfizer Inc.
        11.10.1 Pfizer Inc. Company Details
        11.10.2 Pfizer Inc. Business Overview
        11.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Introduction
        11.10.4 Pfizer Inc. Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.10.5 Pfizer Inc. Recent Development
    11.11 Walvax Biotechnology
        11.11.1 Walvax Biotechnology Company Details
        11.11.2 Walvax Biotechnology Business Overview
        11.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Introduction
        11.11.4 Walvax Biotechnology Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.11.5 Walvax Biotechnology Recent Development
    11.12 Kontec
        11.12.1 Kontec Company Details
        11.12.2 Kontec Business Overview
        11.12.3 Kontec Gene Engineered Subunit Vaccine Introduction
        11.12.4 Kontec Revenue in Gene Engineered Subunit Vaccine Business (2016-2021)
        11.12.5 Kontec Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Gene Engineered Subunit Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Therapeutic Gene Engineered Subunit Vaccine
    Table 3. Key Players of Preventative Gene Engineered Subunit Vaccine
    Table 4. Global Gene Engineered Subunit Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Gene Engineered Subunit Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gene Engineered Subunit Vaccine Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Gene Engineered Subunit Vaccine Market Share by Regions (2016-2021)
    Table 8. Global Gene Engineered Subunit Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Gene Engineered Subunit Vaccine Market Share by Regions (2022-2027)
    Table 10. Gene Engineered Subunit Vaccine Market Trends
    Table 11. Gene Engineered Subunit Vaccine Market Drivers
    Table 12. Gene Engineered Subunit Vaccine Market Challenges
    Table 13. Gene Engineered Subunit Vaccine Market Restraints
    Table 14. Global Gene Engineered Subunit Vaccine Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Gene Engineered Subunit Vaccine Market Share by Players (2016-2021)
    Table 16. Global Top Gene Engineered Subunit Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Engineered Subunit Vaccine as of 2020)
    Table 17. Ranking of Global Top Gene Engineered Subunit Vaccine Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Gene Engineered Subunit Vaccine Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Engineered Subunit Vaccine Product Solution and Service
    Table 21. Date of Enter into Gene Engineered Subunit Vaccine Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Engineered Subunit Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2016-2021)
    Table 25. Global Gene Engineered Subunit Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Gene Engineered Subunit Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Gene Engineered Subunit Vaccine Revenue Market Share by Application (2016-2021)
    Table 29. Global Gene Engineered Subunit Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Gene Engineered Subunit Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Gene Engineered Subunit Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Gene Engineered Subunit Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Gene Engineered Subunit Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Gene Engineered Subunit Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Gene Engineered Subunit Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Gene Engineered Subunit Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Gene Engineered Subunit Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Gene Engineered Subunit Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Gene Engineered Subunit Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Gene Engineered Subunit Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Gene Engineered Subunit Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Gene Engineered Subunit Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Gene Engineered Subunit Vaccine Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Gene Engineered Subunit Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Gene Engineered Subunit Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Gene Engineered Subunit Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Gene Engineered Subunit Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Gene Engineered Subunit Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Gene Engineered Subunit Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Gene Engineered Subunit Vaccine Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Merck Company Details
    Table 62. Merck Business Overview
    Table 63. Merck Gene Engineered Subunit Vaccine Product
    Table 64. Merck Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 65. Merck Recent Development
    Table 66. GSK Company Details
    Table 67. GSK Business Overview
    Table 68. GSK Gene Engineered Subunit Vaccine Product
    Table 69. GSK Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 70. GSK Recent Development
    Table 71. Tiantan Company Details
    Table 72. Tiantan Business Overview
    Table 73. Tiantan Gene Engineered Subunit Vaccine Product
    Table 74. Tiantan Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 75. Tiantan Recent Development
    Table 76. Pulike Company Details
    Table 77. Pulike Business Overview
    Table 78. Pulike Gene Engineered Subunit Vaccine Product
    Table 79. Pulike Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 80. Pulike Recent Development
    Table 81. Greffex Company Details
    Table 82. Greffex Business Overview
    Table 83. Greffex Gene Engineered Subunit Vaccine Product
    Table 84. Greffex Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 85. Greffex Recent Development
    Table 86. CureVac Company Details
    Table 87. CureVac Business Overview
    Table 88. CureVac Gene Engineered Subunit Vaccine Product
    Table 89. CureVac Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 90. CureVac Recent Development
    Table 91. Yebio Company Details
    Table 92. Yebio Business Overview
    Table 93. Yebio Gene Engineered Subunit Vaccine Product
    Table 94. Yebio Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 95. Yebio Recent Development
    Table 96. Sanofi Pasteur SA Company Details
    Table 97. Sanofi Pasteur SA Business Overview
    Table 98. Sanofi Pasteur SA Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 99. Sanofi Pasteur SA Recent Development
    Table 100. Virbac Company Details
    Table 101. Virbac Business Overview
    Table 102. Virbac Gene Engineered Subunit Vaccine Product
    Table 103. Virbac Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 104. Virbac Recent Development
    Table 105. Pfizer Inc. Company Details
    Table 106. Pfizer Inc. Business Overview
    Table 107. Pfizer Inc. Gene Engineered Subunit Vaccine Product
    Table 108. Pfizer Inc. Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 109. Pfizer Inc. Recent Development
    Table 110. Walvax Biotechnology Company Details
    Table 111. Walvax Biotechnology Business Overview
    Table 112. Walvax Biotechnology Gene Engineered Subunit Vaccine Product
    Table 113. Walvax Biotechnology Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 114. Walvax Biotechnology Recent Development
    Table 115. Kontec Company Details
    Table 116. Kontec Business Overview
    Table 117. Kontec Gene Engineered Subunit Vaccine Product
    Table 118. Kontec Revenue in Gene Engineered Subunit Vaccine Business (2016-2021) & (US$ Million)
    Table 119. Kontec Recent Development
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Engineered Subunit Vaccine Market Share by Type: 2020 VS 2027
    Figure 2. Therapeutic Gene Engineered Subunit Vaccine Features
    Figure 3. Preventative Gene Engineered Subunit Vaccine Features
    Figure 4. Global Gene Engineered Subunit Vaccine Market Share by Application: 2020 VS 2027
    Figure 5. Human Use Case Studies
    Figure 6. Veterinary Use Case Studies
    Figure 7. Gene Engineered Subunit Vaccine Report Years Considered
    Figure 8. Global Gene Engineered Subunit Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global Gene Engineered Subunit Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global Gene Engineered Subunit Vaccine Market Share by Regions: 2020 VS 2027
    Figure 11. Global Gene Engineered Subunit Vaccine Market Share by Regions (2022-2027)
    Figure 12. Global Gene Engineered Subunit Vaccine Market Share by Players in 2020
    Figure 13. Global Top Gene Engineered Subunit Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Engineered Subunit Vaccine as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by Gene Engineered Subunit Vaccine Revenue in 2020
    Figure 15. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2016-2021)
    Figure 16. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2022-2027)
    Figure 17. North America Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America Gene Engineered Subunit Vaccine Market Share by Type (2016-2027)
    Figure 19. North America Gene Engineered Subunit Vaccine Market Share by Application (2016-2027)
    Figure 20. North America Gene Engineered Subunit Vaccine Market Share by Country (2016-2027)
    Figure 21. United States Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Gene Engineered Subunit Vaccine Market Share by Type (2016-2027)
    Figure 25. Europe Gene Engineered Subunit Vaccine Market Share by Application (2016-2027)
    Figure 26. Europe Gene Engineered Subunit Vaccine Market Share by Country (2016-2027)
    Figure 27. Germany Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Gene Engineered Subunit Vaccine Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific Gene Engineered Subunit Vaccine Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific Gene Engineered Subunit Vaccine Market Share by Region (2016-2027)
    Figure 37. China Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Gene Engineered Subunit Vaccine Market Share by Type (2016-2027)
    Figure 45. Latin America Gene Engineered Subunit Vaccine Market Share by Application (2016-2027)
    Figure 46. Latin America Gene Engineered Subunit Vaccine Market Share by Country (2016-2027)
    Figure 47. Mexico Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Gene Engineered Subunit Vaccine Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa Gene Engineered Subunit Vaccine Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa Gene Engineered Subunit Vaccine Market Share by Country (2016-2027)
    Figure 53. Turkey Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE Gene Engineered Subunit Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Merck Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 57. GSK Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 58. Tiantan Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 59. Pulike Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 60. Greffex Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 61. CureVac Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 62. Yebio Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 63. Sanofi Pasteur SA Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 64. Virbac Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 65. Pfizer Inc. Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 66. Walvax Biotechnology Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 67. Kontec Revenue Growth Rate in Gene Engineered Subunit Vaccine Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
GSK
Tiantan
Pulike
Greffex
CureVac
Yebio
Sanofi Pasteur SA
Virbac
Pfizer Inc.
Walvax Biotechnology
Kontec
Frequently Asked Questions
Gene Engineered Subunit Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Engineered Subunit Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Engineered Subunit Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lomefloxacin

Lomefloxacin market is segmented by region (country), players, by Type, and by Application. Playe ... Read More

Sodium Cromoglycate

Sodium Cromoglycate market is segmented by region (country), players, by Type, and by Application ... Read More